---
schema_version: "secwatch.filing_event.v1"
accession: "0001725160-22-000129"
form_type: "8-K"
ticker: "ZNTL"
cik: "0001725160"
company_name: "Zentalis Pharmaceuticals, Inc."
filed_at: "2022-06-27T23:59:59+00:00"
generated_at: "2026-06-24T22:58:25.156590+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Chief Legal Officer Alexis M. Pinto resigns from Zentalis, effective July 5, 2022

## Summary
- Alexis M. Pinto notified resignation as Chief Legal Officer and Secretary on June 21, 2022.
- Resignation effective July 5, 2022; no successor named.
- Company filed Form 8-K on June 27, 2022, to report the departure.
- No reason for departure disclosed in the filing.

## SEC filing metadata
- accession: 0001725160-22-000129
- form_type: 8-K
- ticker: ZNTL
- cik: 0001725160
- company_name: Zentalis Pharmaceuticals, Inc.
- filed_at: 2022-06-27T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725160/000172516022000129/0001725160-22-000129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725160/000172516022000129/zntl-20220621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001725160-22-000129
- JSON: https://secwatch.observer/filing/0001725160-22-000129.json
- Plain text: https://secwatch.observer/filing/0001725160-22-000129.txt

## Key facts
- Executive change
  Alexis M. Pinto resigned as Chief Legal Officer and Secretary at Zentalis Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chief Legal Officer and Secretary
  source text: On June 21, 2022, Alexis M. Pinto notified Zentalis Pharmaceuticals, Inc. (the “Company”) of her resignation as Chief Legal Officer and Secretary of the Company, effective as of July 5, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725160/000172516022000129/0001725160-22-000129-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.